Thyme Care Appoints Michael Markowicz as Chief Legal Officer
Published by
Thyme Care
on
Healthcare Legal Expert with Leadership Roles at Evergreen Nephrology, Signify Health, CVS, and Aetna Joins Thyme Care to Drive Value-Based Oncology Care Expansion
NASHVILLE – January 14, 2025 – Thyme Care, the leading value-based cancer care enabler, today announced the appointment of Michael Markowicz as its Chief Legal Officer. A seasoned healthcare legal veteran, Michael brings deep experience in value-based care, regulatory compliance, and corporate transactions to Thyme Care’s leadership team during a period of significant growth.
“From our very first interaction with Michael, it was clear that he not only shared our passion for improving the patient experience in healthcare but also brought the legal expertise necessary to navigate complex value-based contracts. His proven track record of guiding value-based care organizations through periods of rapid expansion, along with his extensive experience at Aetna and CVS, uniquely positions him to excel in this role as we embark on another year of ambitious growth at Thyme Care,” said Robin Shah, co-founder and chief executive officer of Thyme Care.
Before joining Thyme Care, Michael served as General Counsel at Evergreen Nephrology, leading the legal, compliance, privacy, and advocacy functions at a value-based care organization that partners with nephrologists and health plans to improve the quality and reduce the cost of care for patients with late-stage kidney disease. Before Evergreen, he held the role of Deputy General Counsel at Signify Health, where he led the legal team supporting the company’s value-based and episodes of care segment and supported its $564 million initial public offering in 2021.
Earlier in his career, Markowicz worked at CVS/Aetna, where he held several senior legal roles. At CVS Health, he led legal teams focused on value-based contracting across the commercial and Medicaid markets. During his tenure at Aetna, he supported corporate development and played a key role in CVS Health’s acquisition of Aetna, including the divestiture of Aetna’s Medicare Part D business.
“I can’t think of anything more important and inspiring than joining Thyme Care’s mission to improve outcomes for people living with cancer. From my first conversations with Robin and the rest of the leadership team, it was clear Thyme Care had the vision and expertise to make a profound impact on cancer care. I’m eager to bring my experience and my passion for transforming the future of healthcare to Thyme Care,” said Markowicz.
About Thyme Care
Thyme Care is the leading value-based care enabler, collaborating with payers and providers to transform the experience and outcomes for individuals living with cancer. The company partners with health plans, employers and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care. Thyme Care's approach combines a technology-enabled Care Team and seamless integration with more than 800 oncologists in Thyme Care Oncology Partners, creating a hybrid collaborative care model that guides and supports the entire patient journey. Thyme Care empowers oncologists nationwide through purpose-built tech, advanced data analytics, and virtual patient engagement, driving better care and outcomes in value-based arrangements. Thyme Care is a founding member of CancerX, and is backed by leading investors. To learn more about how Thyme Care is enabling the shift to value-based care in oncology, visit www.thymecare.com.
Contact
Kimberly Dreisinger
Thyme Care Communications
Tags:
News & Media